| Literature DB >> 34721620 |
Jiaxi Zhang1, Fei Duan2, Zhihong Zhou1, Li Wang1, Yang Sun1, Jinghan Yang1, Wen Gao1.
Abstract
OBJECTIVE: To explore the relationship between different degrees of compression and clinical symptoms in patients with the myocardial bridge and the risk factors of proximal atherosclerosis.Entities:
Year: 2021 PMID: 34721620 PMCID: PMC8553462 DOI: 10.1155/2021/2087609
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Relationship between different degrees of compression and clinical symptoms in patients with myocardial bridge (n, %, ± s).
| Item | Noble class I ( | Noble class II-III ( |
|
|
|---|---|---|---|---|
| Gender | — | — | 0.514 | 0.474 |
| Man | 59 | 28 | — | — |
| Woman | 43 | 26 | — | — |
| Age (year) | 58.26 ± 7.15 | 60.18 ± 8.72 | 1.476 | 0.142 |
| BMI (kg/m2) | 23.91 ± 5.76 | 24.38 ± 5.50 | 0.492 | 0.623 |
| Hypertension | 52 | 29 | 0.105 | 0.746 |
| Diabetes | 37 | 21 | 0.103 | 0.748 |
| Hyperlipidemia | 25 | 15 | 0.198 | 0.657 |
| Proximal atherosclerotic stenosis of myocardial bridge | 30 | 27 | 6.454 | 0.011 |
| Angina pectoris | 14 | 26 | 21.943 | <0.001 |
| Acute myocardial infarction | 7 | 16 | 14.559 | <0.001 |
Comparison of basic conditions between the control group and the atherosclerosis group (n, %, ± s).
| Item | Control group ( | Atherosclerosis group ( |
|
|
|---|---|---|---|---|
| Gender | — | — | 1.129 | 0.288 |
| Man | 33 | 54 | — | — |
| Woman | 32 | 37 | — | — |
| Age (year) | 58.23 ± 8.68 | 62.10 ± 10.94 | 2.368 | 0.019 |
| BMI (kg/m2) | 24.62 ± 6.01 | 24.75 ± 5.93 | 0.134 | 0.893 |
| MB length (mm) | 12.04 ± 3.69 | 12.58 ± 4.71 | 0.770 | 0.442 |
| MB thickness (mm) | 2.17 ± 1.82 | 1.98 ± 1.63 | 0.683 | 0.495 |
| Hypertension | 18 | 63 | 26.208 | <0.001 |
| Diabetes | 23 | 35 | 0.154 | 0.695 |
| Hyperlipidemia | 12 | 28 | 3.012 | 0.083 |
| Noble classification | — | — | 7.011 | 0.030 |
| Class I | 50 | 52 | — | — |
| Class II | 9 | 19 | — | — |
| Class III | 6 | 20 | — | — |
Comparison of laboratory parameters between the control group and the atherosclerosis group (n, ± s).
| Item | Control group ( | Atherosclerosis group ( |
|
|
|---|---|---|---|---|
| TC (mmol/L) | 4.91 ± 2.63 | 4.09 ± 2.14 | 2.143 | 0.033 |
| TG (mmol/L) | 1.42 ± 1.07 | 1.55 ± 1.10 | 0.735 | 0.462 |
| HDL-C (mmol/L) | 1.20 ± 0.91 | 1.13 ± 0.99 | 0.450 | 0.653 |
| LDL-C (mmol/L) | 2.85 ± 1.36 | 2.67 ± 1.22 | 0.843 | 0.400 |
| CRP (mg/L) | 1.69 ± 1.14 | 2.18 ± 1.25 | 2.502 | 0.013 |
| PLT (×109/L) | 191.34 ± 29.26 | 188.07 ± 31.95 | 0.652 | 0.515 |
Multifactor analysis of proximal atherosclerosis in patients with myocardial bridge.
| Variable |
| SE value | Wald value | OR value | 95% CI |
|
|---|---|---|---|---|---|---|
| Age | 0.426 | 0.204 | 4.361 | 1.531 | 1.026–2.283 | 0.019 |
| Hypertension | 0.261 | 0.117 | 4.976 | 1.298 | 1.032–1.633 | 0.034 |
| Noble classification | 0.357 | 0.142 | 6.321 | 1.429 | 1.081–1.887 | 0.015 |
| TC | 0.155 | 0.168 | 0.851 | 1.167 | 0.840–1.623 | 0.069 |
| CRP | 0.382 | 0.170 | 5.049 | 1.465 | 1.050–2.044 | 0.021 |